Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Engineered T-Cells Tested on Metastatic Cancer

An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells. . . . → Read More: Engineered T-Cells Tested on Metastatic Cancer

Regeneron, Children’s National Partner on Rare Diseases

Regeneron Genetics Center and Children’s National Health System have begun studying thousands of genetic profiles to better understand the causes of rare and undiagnosed disorders. . . . → Read More: Regeneron, Children’s National Partner on Rare Diseases

Laser-Immunotherapy Now in Cancer Clinical Trial

A new type of cancer treatment that precisely attacks tumors with synthetic antibodies activated by laser beams is being tested in an early-stage clinical trial. . . . → Read More: Laser-Immunotherapy Now in Cancer Clinical Trial

Small-Business Grants Awarded for Neurological Diseases

A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders. . . . → Read More: Small-Business Grants Awarded for Neurological Diseases

Zika Vaccine Clinical Trial Underway

The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants. . . . → Read More: Zika Vaccine Clinical Trial Underway

Lilly, Institute Partner on Tuberculosis Drug Discovery

Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis. . . . → Read More: Lilly, Institute Partner on Tuberculosis Drug Discovery

Skin Patch Shown to Increase Peanut Tolerance in Children

A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year. . . . → Read More: Skin Patch Shown to Increase Peanut Tolerance in Children

Therapeutic Food-Triggered Gut Microbes in Development

A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins. . . . → Read More: Therapeutic Food-Triggered Gut Microbes in Development

Funds Provided for Developing RNA-Based Zika Vaccine

Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus. . . . → Read More: Funds Provided for Developing RNA-Based Zika Vaccine

Antibiotic Shown to Control Drug-Resistant Gonorrhea

Findings from a clinical trial show a candidate drug kills bacteria causing a type of gonorrhea becoming resistant to current antibiotics. . . . → Read More: Antibiotic Shown to Control Drug-Resistant Gonorrhea